<DOC>
	<DOCNO>NCT00614432</DOCNO>
	<brief_summary>The primary objective study compare blood loss result surgical termination pregnancy 12 week gestation woman anticoagulated therapeutic level anticoagulated . This study base hypothesis anticoagulant therapy increase intraoperative blood loss woman receive surgical abortion 12 week gestation .</brief_summary>
	<brief_title>Blood Loss Time First Trimester Surgical Abortion Anticoagulated Women</brief_title>
	<detailed_description>We intend conduct prospective cohort study Oregon Health Science University University Hawaii . This study blind subject randomize . Women approach study make decision terminate pregnancy complete preoperative history physical examination surgical consenting process . For patient receive anticoagulant medication , decision continue anticoagulant therapy interrupt make patient 's physician , independently study . We recruit woman continue anticoagulant therapy ( heparin , low molecular weight heparin , warfarin ) without interruption surgical procedure . Our control group consist woman anticoagulant treatment . This match study control group match gestational age , parity , cesarean section history .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Female seek abortion service Less equal 12 week gestation Age 1850 Willing able sign inform consent Use Coumadin LMW heparin ( treatment group ) Unwilling unable sign inform consent Women take daily aspirin herbal therapy contain gingko biloba Women know history bleed disorder von willebrand 's disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>anticoagulation</keyword>
	<keyword>surgical abortion</keyword>
</DOC>